North America Genome Editing Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)

No. of Pages: 155    |    Report Code: TIPRE00003907    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Genome Editing Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Genome Editing Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Genome Editing Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Advancements in CRISPR and gene-editing technologies
  • 5.1.2 Increasing investments in genomic research and personalized medicine
5.2 Market Opportunities
  • 5.2.1 Advancements in genetic research and personalized medicine creating growth opportunities in genome editing technologies
  • 5.2.2 Expanding research funding opening new avenues for innovation
5.3 Future Trends
  • 5.3.1 Application of genome editing for genetic disease treatment
  • 5.3.2 Expanding research in CRISPR technology for genetic therapies
5.4 Impact of Drivers and Restraints

6. North America Genome Editing Market Regional Analysis

6.1 North America Genome Editing Market Overview
6.2 North America Genome Editing Market Revenue 2019-2028 (US$ Million)
6.3 North America Genome Editing Market Forecast Analysis

7. North America Genome Editing Market Analysis – by Technology

7.1 CRISPR
  • 7.1.1 Overview
  • 7.1.2 CRISPR: North America Genome Editing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 TALEN
  • 7.2.1 Overview
  • 7.2.2 TALEN: North America Genome Editing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Antisense
  • 7.3.1 Overview
  • 7.3.2 Antisense: North America Genome Editing Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Genome Editing Market Analysis – by Application

8.1 Cell Line Engineering
  • 8.1.1 Overview
  • 8.1.2 Cell Line Engineering: North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Genetic Engineering
  • 8.2.1 Overview
  • 8.2.2 Genetic Engineering: North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Diagnostic Applications
  • 8.3.1 Overview
  • 8.3.2 Diagnostic Applications: North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Drug Discovery
  • 8.4.1 Overview
  • 8.4.2 Drug Discovery: North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Genome Editing Market Analysis – by End User

9.1 Pharmaceutical and Biotechnology Companies
  • 9.1.1 Overview
  • 9.1.2 Drug Discovery: North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Academic and Research Institutes
  • 9.2.1 Overview
  • 9.2.2 Drug Discovery: North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Clinical Research Organizations
  • 9.3.1 Overview
  • 9.3.2 Drug Discovery: North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Genome Editing Market – North America Analysis

10.1 North America
  • 10.1.1 North America Genome Editing Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Genome Editing Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Genome Editing Market Breakdown, by Technology
    • 10.1.1.1.2 US: North America Genome Editing Market Breakdown, by Application
    • 10.1.1.1.3 US: North America Genome Editing Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Genome Editing Market Breakdown, by Technology
    • 10.1.1.2.2 Canada: North America Genome Editing Market Breakdown, by Application
    • 10.1.1.2.3 Canada: North America Genome Editing Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Genome Editing Market Breakdown, by Technology
    • 10.1.1.3.2 Mexico : North America Genome Editing Market Breakdown, by Application
    • 10.1.1.3.3 Mexico : North America Genome Editing Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Genome Editing Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 MERCK KGaA
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Lonza
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Integrated DNA Technologies
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 GenScript
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 New England Biolabs
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Eurofins Scientific
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 CRISPR Therapeutics
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Editas Medicine
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. THERMO FISHER SCIENTIFIC INC.
  2. MERCK KGaA
  3. Lonza
  4. Horizon Discovery Group plc.            
  5. Integrated DNA Technologies         
  6. GenScript
  7. New England Biolabs
  8. Eurofins Scientific
  9. CRISPR Therapeutics
  10. Editas Medicine               
north-america-genome-editing-market